FDA Drug recall D-1516-201
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by:…
- FDA Drug
- Class III
- terminated
- Published 2016-09-28
On 2016-09-28 the FDA classified a Class III recall of Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by:… by Lupin, citing labeling: Incorrect or Missing Lot and/or Expiration Date.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1516-201 |
| Classification | Class III |
| Status | terminated |
| Initiated | 2016-03-24 |
| Published | 2016-09-28 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Lupin |
| Distribution | US |
Product
Escitalopram Tablets USP 20 mg, 100-count bottles, Rx Only, Manufactured for: Lupin Pharmaceuticals, Baltimore, MD, 21202, Manufactured by: Lupin Limited, Goa 403 722, India, NDC 68180-136-01
Reason
Labeling: Incorrect or Missing Lot and/or Expiration Date
Identifiers
| ndc | 68180-137-01 |
|---|---|
| ndc | 68180-137-06 |
| ndc | 68180-135-01 |
| ndc | 68180-136-01 |
| code_info | Lot # G510086; Exp. 11/17 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1516-201%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.